A patient who is _______ may experience chest tightness, deep sighing breaths, rapid pulse, or cardiac palpitations

Which of the following is TRUE with regard to the FDA and supplement manufacturing?

A) The FDA is responsible for regulating health claims made in advertising dietary supplements. B) Structure/function claims do not require FDA approval, but the manufacturer must provide the FDA with the text of the claim within 30 days of putting the product on the market. C) Supplement companies are required to report all adverse events to the FDA. D) The FDA Manufacturers must provide FDA with evidence of product's safety and efficacy based on clinical trials.

Using an ICD-9-CM code book, select the appropriate code(s) for the diagnostic statements given in the following questions

Infantile obstruction of large intestine